These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6120916)

  • 1. Changes in the prescription of anticholinergic drugs (1970-1977) in a state hospital.
    Craig TJ; Behar R
    Int Pharmacopsychiatry; 1981; 16(2):84-91. PubMed ID: 6120916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations.
    Blazer DG; Federspiel CF; Ray WA; Schaffner W
    J Gerontol; 1983 Jan; 38(1):31-5. PubMed ID: 6129272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-prescription of anticholinergic drugs with neuroleptics.
    Arya DK
    Br J Hosp Med; 1992 Feb 19-Mar 3; 47(4):304. PubMed ID: 1350493
    [No Abstract]   [Full Text] [Related]  

  • 4. Central atropine-like toxicity in combined psychotropic drug administration.
    el-Yousef MK; Davis JM; Janowsky DS; Fann WE
    J Tenn Med Assoc; 1972 Aug; 65(8):719. PubMed ID: 4152620
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacist and physician prescribing for psychiatric inpatients.
    Stimmel GL; McGhan WF; Wincor MZ; Deandrea DM
    Am J Hosp Pharm; 1982 Sep; 39(9):1483-6. PubMed ID: 6127948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing principles for psychotropic medications.
    Shilling K; Reid WH
    Nebr Med J; 1983 Mar; 68(3):56-9. PubMed ID: 6133224
    [No Abstract]   [Full Text] [Related]  

  • 8. Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.
    Patrick V; Schleifer SJ; Nurenberg JR; Gill KJ
    Psychiatr Serv; 2006 Jan; 57(1):21-3. PubMed ID: 16399958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions in psychiatric practice.
    Ragheb M
    Int Pharmacopsychiatry; 1981; 16(2):92-118. PubMed ID: 6120917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of anticholinergic antiparkinson agents against adverse drug reactions in a psychiatric department. A quality assurance project].
    Mikkelsen VR
    Ugeskr Laeger; 1998 Jul; 160(29):4323-5. PubMed ID: 9679438
    [No Abstract]   [Full Text] [Related]  

  • 12. Dosing of second-generation antipsychotic medication in a state hospital system.
    Citrome L; Jaffe A; Levine J
    J Clin Psychopharmacol; 2005 Aug; 25(4):388-91. PubMed ID: 16012286
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state.
    Essock SM; Covell NH; Leckman-Westin E; Lieberman JA; Sederer LI; Kealey E; Finnerty MT
    Psychiatr Serv; 2009 Dec; 60(12):1595-602. PubMed ID: 19952148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic drugs: can education change prescribing practices?
    Schroeder NH; Caffey EM; Lorei TW
    J Clin Psychiatry; 1979 Apr; 40(4):186-9. PubMed ID: 33970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic premedication in Finland 1988.
    Kentala E; Salonen M; Kanto J
    Acta Anaesthesiol Scand; 1990 Jan; 34(1):17-20. PubMed ID: 1968693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic drugs: another survey of prescribing patterns.
    Morgan R; Gopalaswamy AK
    Br J Psychiatry; 1984 Mar; 144():298-302. PubMed ID: 6142744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How dosing of ziprasidone in a state hospital system differs from product labeling.
    Citrome L; Jaffe A; Levine J
    J Clin Psychiatry; 2009 Jul; 70(7):975-82. PubMed ID: 19653974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience.
    Dewa CS; Remington G; Herrmann N; Fearnley J; Goering P
    Clin Ther; 2002 Sep; 24(9):1466-76. PubMed ID: 12380638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring prescribing practices in a state mental hospital system.
    Hartmann K; Allison J; Hartig P
    Hosp Community Psychiatry; 1979 Jul; 30(7):467-9. PubMed ID: 447229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of antipsychotic treatment for schizophrenia in Hong Kong.
    Yip KC; Ungvari GS; Cheung HK; Ng FS; Lau ST
    Chin Med J (Engl); 1997 Oct; 110(10):792-6. PubMed ID: 9642312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.